Enliang Li
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 2
- Surgery 9
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Co-authors
- Tingbo Liang (9 shared papers)Xing Huang (5 shared papers)Gang Zhang (3 shared papers)Xiaozhen Zhang (5 shared papers)Tianyu Tang (4 shared papers)Xun Wang (2 shared papers)Xueli Bai (3 shared papers)Linquan Wu (11 shared papers)
- Journals
- Medicine (4 papers)Powder Technology (3 papers)Advanced Powder Technology (2 papers)Tissue and Cell (1 paper)Microelectronics Reliability (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Enliang Li
48 papers receiving 827 citations
Peers
Comparison fields: 5 of 77
- Oncology 275
- Cancer Research 147
- Hepatology 75
- Immunology 163
- Pulmonary and Respiratory Medicine 114
Countries citing papers authored by Enliang Li
This map shows the geographic impact of Enliang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enliang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enliang Li more than expected).
Fields of papers citing papers by Enliang Li
This network shows the impact of papers produced by Enliang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enliang Li. The network helps show where Enliang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Enliang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 173 | |
| 2 | 2021 | 89 | |
| 3 | 2020 | 57 | |
| 4 | 2017 | 47 | |
| 5 | 1989 | 46 | |
| 6 | 2017 | 39 | |
| 7 | 2021 | 36 | |
| 8 | 2019 | 32 | |
| 9 | 2019 | 31 | |
| 10 | 2021 | 28 | |
| 11 | 2018 | 25 | |
| 12 | 2022 | 22 | |
| 13 | 2020 | 16 | |
| 14 | 2023 | 14 | |
| 15 | 2019 | 14 | |
| 16 | 2022 | 13 | |
| 17 | 2020 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2023 | 11 | |
| 20 | 2017 | 11 |
About Enliang Li
Enliang Li is a scholar working on Molecular Biology, Surgery, Electrical and Electronic Engineering, Pulmonary and Respiratory Medicine and Oncology, having authored 53 papers that have together received 839 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Granular flow and fluidized beds (5 papers), Integrated Circuits and Semiconductor Failure Analysis (4 papers), Gallbladder and Bile Duct Disorders (4 papers), RNA modifications and cancer (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Ubiquitin and proteasome pathways (2 papers) and Geotechnical Engineering and Soil Mechanics (2 papers). The work is most often cited by research in Oncology (275 citations), Cancer Research (147 citations), Hepatology (75 citations), Immunology (163 citations) and Pulmonary and Respiratory Medicine (114 citations). Enliang Li has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Tingbo Liang, Xing Huang, Gang Zhang, Xiaozhen Zhang, Tianyu Tang, Xun Wang, Xueli Bai, Linquan Wu, Wenjun Liao and Jian Xu. Their work appears in journals such as Medicine, Powder Technology, Advanced Powder Technology, Tissue and Cell and Microelectronics Reliability.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.